Evaluation of Novel Tools to Facilitate the Detection and Characterization of Leprosy Patients in China

Table 2

Summarized results of three tests evaluated.

Group		Rapid test	ELISA^1			WBA^2
		NDO-LID	LID-1	NDO-BSA	ND-O-LID	LID-1	ML2044	ML2028
Confirmed patients
MB	20	95% (19)	65% (13)	90% (18)	95% (19)	35% (7)	35% (7)	40% (8)
PB	11	63.6% (7)	36.4% (4)	45.5% (5)	36.4% (4)	72.7% (8)	63.6% (7)	54.5% (6)
At risk
HHC	42	21.4% (9)	0% (0)	35.7% (15)	2.4% (1)	31.0% (13)	23.8% (10)	31.0% (13)
Controls
TB	11	0% (0)	9.1% (1)	9.1% (1)	0% (0)	0% (0)	0% (0)	0% (0)
EC	10	10% (1)	0% (0)	10% (1)	10% (1)	0% (0)	20% (2)	10% (1)
Combined	21	4.8% (1)	4.8% (1)	9.5% (2)	4.8% (1)	0% (0)	9.5% (2)	4.8% (1)

¹ELISA was determined as positive if mean OD of duplicate wells was >2 × EC mean OD.
²WBA were determined as positive if IFN concentration was >50 pg/mL.